Live feed
Filing
SC 13D
SC 13D0001623632-24-000428·FEDERATED HERMES, INC.
Schedule 13D ownership disclosure
FUSION PHARMACEUTICALS INC
Security class unavailable · CUSIP: 36118A100
Event date: 2024-03-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 10,716,153
- Percent of class
- 12.6500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001623632-24-000428
- Form type
- SC 13D
- Filer
- FEDERATED HERMES, INC.
- CIK
- CIK 1056288
- Filed
- Mar 25, 2024
- Reporting period
- Mar 18, 2024
- Description
- Schedule 13D beneficial ownership